HSE National Clinical Guideline
National Clinical Guideline Annual Review and Co-morbidity screening in Paediatric Type 1 Diabetes
Topic:
Paediatric diabetes
Document Owner:
Clinical design and innovation
National Group:
National clinical programme paediatric diabetes
Effective From: 01 October 2020
The aim of this guideline is to provide guidelines for all staff caring for paediatric patients with type 1 diabetes in order to detect co-morbidities or complications and improve their management
Children with a diagnosis of diabetes require intervention, treatment and follow up care from a specialist paediatric team with expertise in managing their condition. Annual review provides an opportunity for the clinician along with the child or young person to review all aspects of their diabetes care including planning for transition to adult services pathway when age appropriate (16-18 years)